MGAT5 and autoimmune disease: In the context of inflammatory and autoimmune diseases, the pro-inflammatory cytokine milieu can promote significant changes in cellular glycosylation, including downregulation of N-acetylglucosaminyltransferase V (MGAT5) expression.